학술논문
586P Safety of tazemetostat (TAZ) in combination with abiraterone/prednisone (A/P) or enzalutamide (E) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S636-S636
Subject
Language
ISSN
0923-7534